Navigation Links
Accuray Receives FDA Clearance for the CyberKnife® System's Lung Optimized Treatment
Date:12/15/2010

gnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 100,000 patients worldwide and currently more than 215 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to market acceptance and clinical acceptance are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products, clinical acceptance and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2010 fiscal year, our form 10-Q filed on November 8, 2010 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forwa
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Accuray Announces Results for First Quarter of Fiscal 2011
2. Accuray Announces Expanded Service Program
3. Accurays CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting
4. Accuray Hires General Manager for the Asia Pacific Region
5. Accuray Incorporated to Speak at Oppenheimers 21st Annual Healthcare Conference
6. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2011
7. Accuray Ranked Number 113 Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
8. Accuray Incorporated to Host Analyst Meeting at ASTRO 2010
9. 100,000th Patient Treated With Accurays CyberKnife® Robotic Radiosurgery System
10. Accuray Awarded $1 Million Grant by U.S. Government
11. Accuray Incorporated to Speak at JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
(Date:6/29/2015)... ... June 29, 2015 , ... San Fernando Valley skin ... tighten sagging skin. Ulthera is a special treatment that offers a way to firm ... to gently stimulate collagen production. Ulthera is highly targeted and precise to help reduce ...
(Date:6/29/2015)... ... June 29, 2015 , ... Bionops Laboratories has released the ... French consumers. , The specialized eye health formulation contains a variety of ingredients ... In addition to Citicoline (Cognizin®), Biomacula provides necessary doses of Vitamin E, Glutathione, ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... of two leaders with the Commercial Markets division, which includes the company’s commercial ... and Minnesota-headquartered companies with regional, national and international reach. Mary Ellen Anderson now ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... and pharmacist guided, safe, informed, responsible and legal access to Health Canada's medical ... West. , NAC provides education on how Health Canada's medical marijuana system works. ...
(Date:6/29/2015)... ... ... Visiting retirement communities and interviewing at-home caregivers has just gotten easier, courtesy ... care on http://www.SeniorsGuideOnline.com . , The helpful “cheat” sheets, like the ones available ... rehab, and nursing home communities . , “’What to Ask When Visiting a ...
Breaking Medicine News(10 mins):Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 3Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 2Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 3Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 2Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 3Health News:New Checklists and Question Sheets for Visiting Retirement Communities, Interviewing Home Health Caregivers Available From Seniors Guide 2Health News:New Checklists and Question Sheets for Visiting Retirement Communities, Interviewing Home Health Caregivers Available From Seniors Guide 3
... 4 Today, the University,HealthSystem Consortium (UHC) announced ... academic medical center (AMC) in Jackson, has,been added ... supply chain,participants., "Moving to UHC for our ... a strategic partner that is committed to meeting ...
... Aug. 3 At my direction,effective noon today, Goshen ... further notice. Earlier today, the National Capital Area,Council (NCAC), ... signs of E. coli bacteria infection. The affected Scouts ... - August 2). As of,today, the source of the ...
... the high cost of health insurance, millions of Americans are ... high cost of health insurance. , ... ... 16 years, www.MyBenefitsPlus.com/gky [AmeriPlan® Corporation] has been ...
... Year." , ... Birmingham, AL (PRWEB) August 3, 2008 ... CEO Jeffrey Tolbert took home two awards in the 12th Annual ... ,AirMed International was announced as the winner in the category of ...
... the University of California, San Diego Medical Center say ... transports stroke specialists via computer desktop or even laptop ... and Internet technology, could have an immediate and profound ... world., Brett C. Meyer, M.D., principal investigator of the ...
... Announcement of increased new infections in 2006 follows nearly two-year ... ... HIV infection,figures by the Centers for Disease Control and Prevention (CDC) ... 56,300. Though,the agency says the one-year revision does not necessarily indicate ...
Cached Medicine News:Health News:University of Mississippi Health Care Selects UHC for Group Purchasing Services 2Health News:AmeriPlan Offers Affordable Money-Saving Discount Healthcare Programs for the Uninsured and Underinsured 2Health News:Air Ambulance Company AirMed International Wins Multiple "Best in Business" Awards from Birmingham Business Journal 2Health News:Telemedicine leads to better stroke treatment decisions 2Health News:Telemedicine leads to better stroke treatment decisions 3Health News:New HIV Infection Figures from CDC Underscore Need for National AIDS Strategy for the U.S. 2
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: